Global Infertility Treatment Market is Estimated to Value Over USD 2.8 Billion by 2026 End

  • 14 Aug 2019

Global Infertility Treatment Market is estimated to value over USD 2.8 billion by 2026 end and register CAGR of over 7.8% during the forecast period 2019-2026.

Increasing delayed pregnancy cases and soaring rise in the rate of infertility owing to a stressful lifestyle and consumption of alcohol, tobacco are primary driving factors for the infertility treatment market. Additionally, advancements in medical technologies in IVF devices worldwide is projected to spur the market growth. Moreover, governments across the world are taking initiatives regarding fertility treatment, especially in emerging economies along with availability and development of innovative minimally invasive treatments which has boosted the market further.

Nevertheless, these fertility treatments are costly. Furthermore, infertility treatments have some issues like ovarian hyperstimulation syndrome (OHSS), bleeding or infection and the most commonly observed problem, multiple pregnancy. All these factors can significantly impede market growth.

Increasing incidences of obesity and diabetes, environmental effects like air pollution and changing lifestyle are some integral factors leading to infertility in both women and men. According to the data reported by WHO, over 600 million people are identified as overweight and over 2 million people around the world are diagnosed with obesity. Additionally, workplace stress is another contributing factor for increase in infertility cases.

However, patients get stressed due to treatment failures which is a key impedance for market growth. Treatment failures may aggravate stress levels in patients who are already under stress for getting diagnosed with infertility. Additionally, social taboos and high infertility treatment costs pose difficult challenges for market growth. Majority of male patients, especially from the developing nations, are ashamed to accept their infertility and often deny it. Besides this, a lack of awareness in emerging economies regarding infertility treatments is further hampering the market growth.

Artificial Insemination is Projected to Grow Rapidly During the Forecast Period

Artificial insemination reduces pregnancy-related complications which is a key factor for the proliferation of the market. The artificial insemination market is further segmented into intratubal insemination, intrauterine insemination and intracervical insemination. Intrauterine insemination sub segment accounts for the largest market share in the artificial insemination segment.

North America leads the global infertility treatment market owing growing median age of first-time pregnancy, decreasing fertility rates, presence of key market players like Cook Group Inc., The Cooper Companies, Hamilton Throne Ltd., and increasing healthcare expenditure are integral factors in driving the market growth in the region.

Recent Developments:

  • Genea Ltd., expanded its market in Melbourne in March 2018 with the establishment of a new fertility clinic in Melbourne
  • Baker Ruskinn partnered with I&L Biosystems UK Ltd. In April 2018 for the expansion of distribution and sales thus strengthening its market presence in the UK market
  • Vitrolife AB, Sweden got its time-lapse incubator EmbryoScope+ approved in March 2018 which has inflated its market visibility and product sales in the US market

FutureWise Key Takeaways:

  • Stressful lifestyle and consumption of unhealthy products like tobacco and alcohol are primary reasons of infertility and its soaring rise has increased the demand for infertility treatment market
  • The high costs of treatments and societal pressures on patients can significantly affect the market growth especially in the developing economies

Global Infertility Treatment Market Segmentation:

By Product

  • Equipment
    1. Microscopes
    2. Imaging Systems
    3. Sperm Analyzer Systems
    4. Ovum aspiration Pumps
    5. Micromanipulator Systems
    6. Incubators
    7. Gas Analyzers
    8. Laser Systems
    9. Cryo Systems
  • Media & Consumables
  • Accessories

By Procedure

  • In Vitro Fertilization
  • Artificial Insemination
    1. Intrauterine Insemination
    2. Intracervical Insemination
    3. Intratubal Insemination
  • Fertility Surgery
    1. Laparoscopy
    2. Hysteroscopy
    3. Myomectomy
    4. Laparotomy
    5. Tubal Ligation Reversal
    6. Varicocelectomy
    7. Microsurgical Reconstruction
    8. Vasovasostomy
    9. Vasoepididymostomy
  • Others

By Patient Type

  • Female Infertility Treatment
  • Male Infertility Treatment

By End User

  • Fertility Centres
  • Hospitals and Surgical Clinics
  • Research Institutes
  • Cryobanks

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape:

  • Tier 1 players- established companies in the market with a major market share  
  • Tier 2 players 
  • Emerging players which are growing rapidly 
  • New Entrants

Objectives of the Study:

  • To provide with an exhaustive analysis on the shoulder replacement market by product, by procedure, by patient type, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com